CSF levels of sTREM2 in AD patients positively correlated with the levels of the neurodegenerative markers Aβ42 and T-tau/P-tau in the CSF indicating co-occurrence of AD pathology and microglia activation [197–200]. This evidence concerns the gene MAPT and Alzheimer disease.